Lyfegen

Lyfegen provides automated drug rebate management technology for healthcare payers and pharmaceutical companies. Its platform streamlines complex agreements, improves compliance, and enhances operational efficiency, resulting in cost savings and improved patient access to treatments. The company serves clients across Europe, North America, and the Middle East.

Funding Round: Series A

Funding Amount: CHF5M

Date: 11-Dec-2024

Investors: TX Ventures, aMoon, other institutional investors

Markets: Healthtech, Fintech, Hospitals and Health Care, Electronic Health Record (EHR), Enterprise Software, Health Insurance, Pharmaceutical

HQ: Basel, Basel-Stadt, Switzerland

Founded: 2018

Website: https://lyfegen.com/

LinkedIn: https://www.linkedin.com/company/lyfegen

Twitter: https://twitter.com/LyfegenHealth

Instagram:

Facebook: https://www.facebook.com/lyfegen